Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.7010
-0.0127-1.78%
Post-market: 0.70100.00000.00%19:41 EDT
Volume:160.56K
Turnover:113.29K
Market Cap:88.43M
PE:-1.28
High:0.7197
Open:0.7000
Low:0.7000
Close:0.7137
Loading ...
Mar 01, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 23, 2023

Major Issues Report

8-K - Current report
Feb 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 01, 2022

Major Issues Report

8-K - Current report
Nov 01, 2022

Major Issues Report

8-K/A [Amend] - Current report
Nov 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 02, 2022

Major Issues Report

8-K - Current report
Aug 02, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 16, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Major Issues Report

8-K - Current report
May 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 02, 2021

Major Issues Report

8-K - Current report